Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$175.10M
Total Bought:
$26.81M
Total Sold:
$27.51M
Net Transaction:
-$698.8K
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)14,250,00011,975,000-2,275,000$53.44M$63.35M36.18%+$9.91M
Atea Pharmaceuticals, Inc.(AVIR)7,058,6576,952,330-106,327$37.98M$32.33M18.46%-$5.65M
enGene Therapeutics Inc.COM A(ENGN)06,669,908+6,669,908$0$11.54M6.59%+$11.54M
The Kraft Heinz Company(KHC)125,000465,000+340,000$2.81M$10.98M6.27%+$8.17M
Outset Medical, Inc.(OM)1,902,2012,519,701+617,500$7.30M$10.89M6.22%+$3.58M
CarMax, Inc.(KMX)155,000172,500+17,500$6.44M$9.12M5.21%+$2.68M
Tilly's, Inc.CL A(TLYS)2,150,0002,150,0000$8.71M$9.03M5.16%+$322.5K
PMV Pharmaceuticals, Inc.(PMVP)5,320,0005,330,000+10,000$6.60M$7.14M4.08%+$545.4K
Instil Bio, Inc.(TIL)645,600645,6000$5.32M$4.96M2.84%-$355.1K
Target Corporation(TGT)37,50037,5000$4.54M$4.90M2.80%+$352.9K
Oramed Pharmaceuticals Inc.(ORMP)3,167,231866,269-2,300,962$10.77M$4.17M2.38%-$6.60M
Janux Therapeutics, Inc.(JANX)154,961154,9610$2.15M$2.38M1.36%+$226.2K
Pliant Therapeutics, Inc.(PLRX)1,546,1371,546,1370$1.95M$1.76M1.01%-$185.5K
Connect Biopharma Holdings LimitedSHS(CNTB)408,887573,287+164,400$1.07M$1.36M0.78%+$293.1K
ImageneBio, Inc.(IMA)200,730200,7300$1.00M$1.18M0.68%+$180.7K
Kezar Life Sciences Inc
COM NEW
720,7870-720,787$5.35M$0—-$5.35M
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q2 2026 | TickerTrail